FHIR IG analytics| Package | us.nlm.vsac |
| Resource Type | ValueSet |
| Id | ValueSet-2.16.840.1.113762.1.4.1146.2662.json |
| FHIR Version | R4 |
| Source | https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1146.2662/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2662 |
| Version | 20250621 |
| Status | active |
| Date | 2025-06-21T01:03:03-04:00 |
| Name | MoxifloxacinRXNORM |
| Title | Moxifloxacin (RXNORM) |
| Realm | us |
| Authority | hl7 |
| Description | All prescribable medication formulations represented using either a "generic" or "brand-specific" concept. This includes RxNorm codes whose Term Type is SCD (semantic clinical drug), SBD (semantic brand drug), GPCK (generic pack), or BPCK (brand pack). SCDG (semantic clinical drug group), SBDG (semantic brand drug group), SCDF (semantic clinical drug form), IN (ingredient) or SBDF (semantic brand drug form) are NOT included in this value set. |
| Purpose | (Clinical Focus: This set of values contains codes for prescribable medications for Moxifloxacin),(Data Element Scope: medications that were administered, ordered or prescribed.),(Inclusion Criteria: Moxifloxacin),(Exclusion Criteria: SBDG (semantic brand drug group), SCDF (semantic clinical drug form), or SBDF (semantic brand drug form).) |
No resources found
| CodeSystem | |
| rxnorm | RxNorm |
No narrative content found in resource
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113762.1.4.1146.2662",
"meta": {
"versionId": "8",
"lastUpdated": "2025-06-21T01:03:03.000-04:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "CSTE Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-keyWord",
"valueString": "G_Common,Meds"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2025-06-21"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2025-06-21"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2662",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113762.1.4.1146.2662"
}
],
"version": "20250621",
"name": "MoxifloxacinRXNORM",
"title": "Moxifloxacin (RXNORM)",
"status": "active",
"date": "2025-06-21T01:03:03-04:00",
"publisher": "CSTE Steward",
"description": "All prescribable medication formulations represented using either a \"generic\" or \"brand-specific\" concept. This includes RxNorm codes whose Term Type is SCD (semantic clinical drug), SBD (semantic brand drug), GPCK (generic pack), or BPCK (brand pack).\nSCDG (semantic clinical drug group), SBDG (semantic brand drug group), SCDF (semantic clinical drug form), IN (ingredient) or SBDF (semantic brand drug form) are NOT included in this value set.",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: This set of values contains codes for prescribable medications for Moxifloxacin),(Data Element Scope: medications that were administered, ordered or prescribed.),(Inclusion Criteria: Moxifloxacin),(Exclusion Criteria: SBDG (semantic brand drug group), SCDF (semantic clinical drug form), or SBDF (semantic brand drug form).)",
"compose": {
"include": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept": [
{
"code": "261339",
"display": "moxifloxacin 400 MG Oral Tablet [Avelox]"
},
{
"code": "311787",
"display": "moxifloxacin 400 MG Oral Tablet"
},
{
"code": "351156",
"display": "250 ML moxifloxacin 1.6 MG/ML Injection"
},
{
"code": "403818",
"display": "moxifloxacin 5 MG/ML Ophthalmic Solution"
},
{
"code": "404473",
"display": "moxifloxacin 5 MG/ML Ophthalmic Solution [Vigamox]"
},
{
"code": "860777",
"display": "250 ML moxifloxacin 1.6 MG/ML Injection [Avelox]"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:c03e3560-874b-4f7f-9436-da44a02f7f99",
"timestamp": "2025-11-24T13:33:24-05:00",
"total": 6,
"contains": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "09022025",
"code": "261339",
"display": "moxifloxacin 400 MG Oral Tablet [Avelox]"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "09022025",
"code": "311787",
"display": "moxifloxacin 400 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "09022025",
"code": "351156",
"display": "250 ML moxifloxacin 1.6 MG/ML Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "09022025",
"code": "403818",
"display": "moxifloxacin 5 MG/ML Ophthalmic Solution"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "09022025",
"code": "404473",
"display": "moxifloxacin 5 MG/ML Ophthalmic Solution [Vigamox]"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "09022025",
"code": "860777",
"display": "250 ML moxifloxacin 1.6 MG/ML Injection [Avelox]"
}
]
}
}